Willie JT, Chemelli RM, Sinton CM, Yanagisawa M (2001). „To eat or to sleep? Orexin in the regulation of feeding and wakefulness.”. Annu. Rev. Neurosci.24: 429–58. DOI:10.1146/annurev.neuro.24.1.429. PMID11283317.
Hungs M, Mignot E (2001). „Hypocretin/orexin, sleep and narcolepsy.”. Bioessays23 (5): 397–408. DOI:10.1002/bies.1058. PMID11340621.
Sakurai T, Amemiya A, Ishii M, et al. (1998). „Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior.”. Cell92 (5): 697. DOI:10.1016/S0092-8674(02)09256-5. PMID9527442.
Peyron C, Faraco J, Rogers W, et al. (2000). „A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains.”. Nat. Med.6 (9): 991–7. DOI:10.1038/79690. PMID10973318.
Blanco M, López M, GarcIa-Caballero T, et al. (2001). „Cellular localization of orexin receptors in human pituitary.”. J. Clin. Endocrinol. Metab.86 (7): 3444–7. DOI:10.1210/jc.86.7.3444. PMID11443222.
Olafsdóttir BR, Rye DB, Scammell TE, et al. (2002). „Polymorphisms in hypocretin/orexin pathway genes and narcolepsy.”. Neurology57 (10): 1896–9. PMID11723285.
Wieland HA, Söll RM, Doods HN, et al. (2002). „The SK-N-MC cell line expresses an orexin binding site different from recombinant orexin 1-type receptor.”. Eur. J. Biochem.269 (4): 1128–35. DOI:10.1046/j.0014-2956.2001.02739.x. PMID11856342.
Hilairet S, Bouaboula M, Carrière D, et al. (2003). „Hypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716.”. J. Biol. Chem.278 (26): 23731–7. DOI:10.1074/jbc.M212369200. PMID12690115.
Karteris E, Chen J, Randeva HS (2004). „Expression of human prepro-orexin and signaling characteristics of orexin receptors in the male reproductive system.”. J. Clin. Endocrinol. Metab.89 (4): 1957–62. DOI:10.1210/jc.2003-031778. PMID15070969.
Holmqvist T, Johansson L, Ostman M, et al. (2005). „OX1 orexin receptors couple to adenylyl cyclase regulation via multiple mechanisms.”. J. Biol. Chem.280 (8): 6570–9. DOI:10.1074/jbc.M407397200. PMID15611118.
Spinazzi R, Rucinski M, Neri G, et al. (2005). „Preproorexin and orexin receptors are expressed in cortisol-secreting adrenocortical adenomas, and orexins stimulate in vitro cortisol secretion and growth of tumor cells.”. J. Clin. Endocrinol. Metab.90 (6): 3544–9. DOI:10.1210/jc.2004-2385. PMID15797953.
Meerabux J, Iwayama Y, Sakurai T, et al. (2005). „Association of an orexin 1 receptor 408Val variant with polydipsia-hyponatremia in schizophrenic subjects.”. Biol. Psychiatry58 (5): 401–7. DOI:10.1016/j.biopsych.2005.04.015. PMID15978554.
Ziolkowska A, Spinazzi R, Albertin G, et al. (2006). „Orexins stimulate glucocorticoid secretion from cultured rat and human adrenocortical cells, exclusively acting via the OX1 receptor.”. J. Steroid Biochem. Mol. Biol.96 (5): 423–9. DOI:10.1016/j.jsbmb.2005.05.003. PMID16157481.
Spoljašnje veze
„Orexin Receptors: OX1”. IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Arhivirano iz originala na datum 2016-02-06.